XML 127 R114.htm IDEA: XBRL DOCUMENT v3.8.0.1
Schedule II - Condensed Financial Information of Registrant (Statements of Cash Flows (Parent Company)) (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Condensed Cash Flow Statements, Captions [Line Items]                      
Fixed maturity securities available for sale at fair value (cost $1,059,834 and $899,206 at December 31, 2017 and 2016, respectively) $ 13,551,250       $ 13,190,668       $ 13,551,250 $ 13,190,668  
Cash flows from operating activities:                      
Net income 154,589 $ 162,054 $ 109,004 $ 123,447 152,790 $ 220,650 $ 108,967 $ 119,511 549,094 601,916 $ 503,694
Adjustments to reconcile net income to net cash from operating activities:                      
Net investment gains (losses)                 (335,858) (267,005) (92,324)
Depreciation and amortization                 112,956 86,051 85,139
Stock incentive plans                 40,490 37,174 32,123
Change in:                      
Other liabilities                 66,482 46,852 (63,680)
Net cash from operating activities                 710,883 848,376 881,304
Cash (used in) from investing activities:                      
Proceeds from sale of fixed maturity securities                 4,035,162 2,440,310 1,388,680
Proceeds from maturities and prepayments of fixed maturity securities                 3,556,744 2,189,365 2,999,339
Proceeds from sales of equity securities                 195,270 143,042 15,833
Cost of purchases of fixed maturity securities                 (7,940,957) (5,541,202) (4,455,223)
Change in loans receivable                 27,135 166,327 48,909
Net additions to real estate, furniture & equipment                 (115,719) (50,829) (63,562)
Net cash used in investing activities                 (333,464) (794,488) (170,763)
Cash (used in) from financing activities:                      
Purchase of common treasury shares                 (47,807) (132,392) (223,652)
Cash dividends to common stockholders                 (188,199) (183,999) (58,034)
Net cash used in financing activities                 (235,086) (6,932) (555,318)
Net increase in cash and cash equivalents                 155,186 31,654 89,190
Cash and cash equivalents at beginning of year       795,285       763,631 795,285 763,631 674,441
Cash and cash equivalents at end of year 950,471       795,285       950,471 795,285 763,631
Parent Company                      
Condensed Cash Flow Statements, Captions [Line Items]                      
Fixed maturity securities available for sale at fair value (cost $1,059,834 and $899,206 at December 31, 2017 and 2016, respectively) 1,052,240       894,748       1,052,240 894,748  
Cash flows from operating activities:                      
Net income 549,094               549,094 601,916 503,694
Adjustments to reconcile net income to net cash from operating activities:                      
Net investment gains (losses)                 4,286 3,649 (696)
Depreciation and amortization                 2,039 2,744 2,693
Equity in undistributed earnings of subsidiaries                 (222,390) (103,941) (46,113)
Tax payments received from subsidiaries                 98,313 414,386 311,482
Federal income taxes provided by subsidiaries on a separate return basis                 (115,597) (327,520) (272,180)
Stock incentive plans                 38,075 37,174 29,725
Change in:                      
Federal income taxes                 2,711 44,839 51,772
Other assets                 (877) 1,772 301
Other liabilities                 18,661 (88,282) (92,752)
Accrued investment income                 (2,818) (2,743) 524
Net cash from operating activities                 371,497 583,994 488,450
Cash (used in) from investing activities:                      
Proceeds from sale of fixed maturity securities                 849,330 373,252 380,986
Proceeds from maturities and prepayments of fixed maturity securities                 316,611 210,904 123,639
Proceeds from sales of equity securities                 0 0 308
Cost of purchases of fixed maturity securities                 (1,329,379) (1,285,101) (432,645)
Change in loans receivable                 (29,600) (23,419) 0
Investments in and advances to subsidiaries, net                 (21,139) 11,471 30,338
Net additions to real estate, furniture & equipment                 (1,055) (3,042) (4,425)
Net cash used in investing activities                 (215,232) (715,935) 98,201
Cash (used in) from financing activities:                      
Net proceeds from issuance of senior notes                 0 386,830 0
Repayment of senior notes                 0 (9,353) (200,000)
Purchase of common treasury shares                 (47,807) (132,392) (223,652)
Cash dividends to common stockholders                 (188,199) (183,999) (58,034)
Net cash used in financing activities                 (236,006) 61,086 (481,686)
Net increase in cash and cash equivalents                 (79,741) (70,855) 104,965
Cash and cash equivalents at beginning of year       $ 124,803       $ 195,658 124,803 195,658  
Cash and cash equivalents at end of year $ 45,062       $ 124,803       $ 45,062 $ 124,803 $ 195,658